Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-061713
Filing Date
2011-11-08
Accepted
2011-11-07 18:15:45
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-25667_110q.htm 10-Q 1010936
2 EX-10.1 a11-25667_1ex10d1.htm EX-10.1 486809
3 EX-31.1 a11-25667_1ex31d1.htm EX-31.1 10695
4 EX-31.2 a11-25667_1ex31d2.htm EX-31.2 10700
5 EX-32.1 a11-25667_1ex32d1.htm EX-32.1 8637
  Complete submission text file 0001104659-11-061713.txt   8460353

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT isis-20110930.xml EX-101.INS 1190596
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isis-20110930.xsd EX-101.SCH 66282
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT isis-20110930_cal.xml EX-101.CAL 49037
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT isis-20110930_lab.xml EX-101.LAB 852557
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isis-20110930_pre.xml EX-101.PRE 378181
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT isis-20110930_def.xml EX-101.DEF 299014
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 111185775
SIC: 2834 Pharmaceutical Preparations